Rej, R.K.; Allu, S.R.; Roy, J.; Acharyya, R.K.; Kiran, I.N.C.; Addepalli, Y.; Dhamodharan, V.
Orally Bioavailable Proteolysis-Targeting Chimeras: An Innovative Approach in the Golden Era of Discovering Small-Molecule Cancer Drugs. Pharmaceuticals 2024, 17, 494.
https://doi.org/10.3390/ph17040494
AMA Style
Rej RK, Allu SR, Roy J, Acharyya RK, Kiran INC, Addepalli Y, Dhamodharan V.
Orally Bioavailable Proteolysis-Targeting Chimeras: An Innovative Approach in the Golden Era of Discovering Small-Molecule Cancer Drugs. Pharmaceuticals. 2024; 17(4):494.
https://doi.org/10.3390/ph17040494
Chicago/Turabian Style
Rej, Rohan Kalyan, Srinivasa Rao Allu, Joyeeta Roy, Ranjan Kumar Acharyya, I. N. Chaithanya Kiran, Yesu Addepalli, and V. Dhamodharan.
2024. "Orally Bioavailable Proteolysis-Targeting Chimeras: An Innovative Approach in the Golden Era of Discovering Small-Molecule Cancer Drugs" Pharmaceuticals 17, no. 4: 494.
https://doi.org/10.3390/ph17040494
APA Style
Rej, R. K., Allu, S. R., Roy, J., Acharyya, R. K., Kiran, I. N. C., Addepalli, Y., & Dhamodharan, V.
(2024). Orally Bioavailable Proteolysis-Targeting Chimeras: An Innovative Approach in the Golden Era of Discovering Small-Molecule Cancer Drugs. Pharmaceuticals, 17(4), 494.
https://doi.org/10.3390/ph17040494
